Jianxin Hu

Jianxin Hu is a seasoned professional in process and analytical development with extensive experience in the biotechnology sector. Currently serving as Senior Director and Head of Process and Analytical Development at Vor Bio since February 2021, Jianxin has effectively led a team of 25 scientists. Prior roles include positions at Takeda, where Jianxin advanced an iPSC-derived cell therapy and collaborated with Memorial Sloan Kettering Cancer Center on gene-edited CAR-T therapies. Earlier, Jianxin worked at Biogen, establishing genome engineering infrastructure, and held postdoctoral and visiting scholar positions at UCSF and NHGRI, respectively. Jianxin holds a PhD in Molecular Genetics and has contributed to significant advancements in gene editing technologies and cell therapies throughout a robust career.